GeneOne Life Science, Inc. (KRX:011000)
South Korea
· Delayed Price · Currency is KRW 1,040.00
-44.00 (-4.06%)
Mar 9, 2026, 3:30 PM KST
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 5.08B KRW in the quarter ending September 30, 2025, a decrease of -42.92%. This brings the company's revenue in the last twelve months to 30.90B, down -18.62% year-over-year. In the year 2024, GeneOne Life Science had annual revenue of 35.72B, down -11.15%.
Revenue (ttm)
30.90B
Revenue Growth
-18.62%
P/S Ratio
2.87
Revenue / Employee
753.61M
Employees
41
Market Cap
88.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
| Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
| Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
| Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
| Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amicogen | 87.97B |
| IMB Dx | 4.26B |
| Oncocross | 884.68M |
| CG Invites | 18.12B |
| ORIENT BIO | 59.09B |
| ENCell | 5.91B |
| Macrogen | 179.98B |
| Vaxcell-Bio Therapeutics | 1.90B |